Anaphylaxis Alert: Herbal Remedy Under Scrutiny!
January 21, 2026: A Potential Health Hazard?
The herbal remedy Andrographis paniculata is facing scrutiny due to an alarming number of reported cases of anaphylaxis and severe allergic reactions. This has prompted an urgent safety review, leaving users and experts alike on edge.
The Therapeutic Goods Administration (TGA) is leading the investigation, revealing that over 1,300 adverse events related to andrographis have been documented. These include life-threatening anaphylaxis, respiratory issues, and rashes, with a tragic death attributed to anaphylaxis. But here's where it gets controversial—andrographis is a popular ingredient in cold and flu remedies, often marketed for immune support.
With approximately 100 products containing andrographis registered in Australia, the TGA has been monitoring its safety since 2008. In 2019, they mandated warning labels, advising users of potential allergic reactions and instructing them to seek medical help for severe symptoms.
However, the TGA admits that the risk factors for andrographis allergy remain largely unknown. They are now evaluating if the current warning labels are adequate, leaving users with a pressing question: Are these remedies safe?
Health professionals are urged to caution patients about the potential risks and advise them to steer clear of andrographis if they've experienced any allergic reactions. Additionally, those with a history of severe allergies are recommended to avoid andrographis-containing products altogether.
As the investigation unfolds, the TGA's decision could significantly impact the herbal supplement industry. Will the review lead to stricter regulations or even a ban? Stay tuned as we await further guidance from the TGA in early 2026. Your health and safety may depend on it!
For more details, refer to the full Pharmacy Daily newsletter from January 21, 2026, available for download via the provided link.
